We found that high miR-20b expression indicates poor prognosis in AML patients receiving chemotherapy only, and it coexists with known adverse prognostic factors such as TP53 mutation and old age but not with known favorable prognostic factors such as RUNX1-RUNX1T and CBFβ-MYH11. This evidence concerns the gene MYH11 and acute myeloid leukemia.